Squarepoint
NARI

Squarepoint’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Squarepoint’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-97,700
Closed -$6.34M – 4730
2023
Q4 		$6.34M Buy
97,700
+18,900
+24% +$1.14M 0.01% 1241
2023
Q3 		$5.15M Buy
+78,800
New +$4.96M 0.01% 1164

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Squarepoint's NARI Position: Q1 2025 in Review

Squarepoint sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 192,115 shares — an estimated $9.81M sold.

Squarepoint first reported a position in NARI in Q2 2021 and held it in 14 quarters. The position peaked at $11.6M in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Squarepoint reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Squarepoint sold 192,115 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $9.81M.
  • Squarepoint first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 14 quarters.
  • Squarepoint's Inari Medical, Inc. Common Stock position peaked at $11.6M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.